OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dendritic Cells and Their Role in Immunotherapy
Alycia Gardner, Álvaro de Mingo Pulido, Brian Ruffell
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 395
Alycia Gardner, Álvaro de Mingo Pulido, Brian Ruffell
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 395
Showing 26-50 of 395 citing articles:
Plasmacytoid Dendritic Cell (pDC) Infiltration Correlate with Tumor Infiltrating Lymphocytes, Cancer Immunity, and Better Survival in Triple Negative Breast Cancer (TNBC) More Strongly than Conventional Dendritic Cell (cDC)
Masanori Oshi, Stephanie Newman, Yoshihisa Tokumaru, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3342-3342
Open Access | Times Cited: 90
Masanori Oshi, Stephanie Newman, Yoshihisa Tokumaru, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3342-3342
Open Access | Times Cited: 90
DC-Derived Exosomes for Cancer Immunotherapy
Yi Yao, Chunmei Fu, Li Zhou, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3667-3667
Open Access | Times Cited: 77
Yi Yao, Chunmei Fu, Li Zhou, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3667-3667
Open Access | Times Cited: 77
Engineering Nanoscale Artificial Antigen-Presenting Cells by Metabolic Dendritic Cell Labeling to Potentiate Cancer Immunotherapy
Ping Xiao, Jue Wang, Zitong Zhao, et al.
Nano Letters (2021) Vol. 21, Iss. 5, pp. 2094-2103
Closed Access | Times Cited: 64
Ping Xiao, Jue Wang, Zitong Zhao, et al.
Nano Letters (2021) Vol. 21, Iss. 5, pp. 2094-2103
Closed Access | Times Cited: 64
Immunotherapies for hepatocellular carcinoma
Justin K. H. Liu, Andrew F. Irvine, Rebecca Jones, et al.
Cancer Medicine (2021) Vol. 11, Iss. 3, pp. 571-591
Open Access | Times Cited: 63
Justin K. H. Liu, Andrew F. Irvine, Rebecca Jones, et al.
Cancer Medicine (2021) Vol. 11, Iss. 3, pp. 571-591
Open Access | Times Cited: 63
Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective
Ranran Wang, Tianyi Yuan, Jianmei Wang, et al.
Pharmacological Research (2022) Vol. 180, pp. 106238-106238
Closed Access | Times Cited: 63
Ranran Wang, Tianyi Yuan, Jianmei Wang, et al.
Pharmacological Research (2022) Vol. 180, pp. 106238-106238
Closed Access | Times Cited: 63
NK cells with tissue-resident traits shape response to immunotherapy by inducing adaptive antitumor immunity
Nicole Kirchhammer, Marcel P. Trefny, Marina Natoli, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 653
Open Access | Times Cited: 63
Nicole Kirchhammer, Marcel P. Trefny, Marina Natoli, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 653
Open Access | Times Cited: 63
Recent Advances in Experimental Dendritic Cell Vaccines for Cancer
Ivan Y. Filin, Kristina V. Kitaeva, Catrin S. Rutland, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 57
Ivan Y. Filin, Kristina V. Kitaeva, Catrin S. Rutland, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 57
Tumor microenvironment of human breast cancer, and feline mammary carcinoma as a potential study model
Catarina Nascimento, Fernando Ferreira
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 1, pp. 188587-188587
Open Access | Times Cited: 56
Catarina Nascimento, Fernando Ferreira
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 1, pp. 188587-188587
Open Access | Times Cited: 56
Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy
Judy R. van Beijnum, Elisabeth J. M. Huijbers, Karlijn van Loon, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 52
Judy R. van Beijnum, Elisabeth J. M. Huijbers, Karlijn van Loon, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 52
Plasmacytoid Dendritic Cells and Cancer Immunotherapy
Chunmei Fu, Li Zhou, Qing‐Sheng Mi, et al.
Cells (2022) Vol. 11, Iss. 2, pp. 222-222
Open Access | Times Cited: 46
Chunmei Fu, Li Zhou, Qing‐Sheng Mi, et al.
Cells (2022) Vol. 11, Iss. 2, pp. 222-222
Open Access | Times Cited: 46
Application of dendritic cells in tumor immunotherapy and progress in the mechanism of anti-tumor effect of Astragalus polysaccharide (APS) modulating dendritic cells: a review
Dong Wang, Qian Cui, Yan Yang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113541-113541
Open Access | Times Cited: 45
Dong Wang, Qian Cui, Yan Yang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113541-113541
Open Access | Times Cited: 45
The systemic-level repercussions of cancer-associated inflammation mediators produced in the tumor microenvironment
Dolores Aguilar-Cázares, Rodolfo Chavez-Dominguez, Mario Marroquin-Muciño, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 38
Dolores Aguilar-Cázares, Rodolfo Chavez-Dominguez, Mario Marroquin-Muciño, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 38
Single-cell spatial landscape of immunotherapy response reveals mechanisms of CXCL13 enhanced antitumor immunity
Mark Sorin, Elham Karimi, Morteza Rezanejad, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 2, pp. e005545-e005545
Open Access | Times Cited: 37
Mark Sorin, Elham Karimi, Morteza Rezanejad, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 2, pp. e005545-e005545
Open Access | Times Cited: 37
Common mechanisms underlying diabetic vascular complications: focus on the interaction of metabolic disorders, immuno-inflammation, and endothelial dysfunction
Chongxiang Xue, Keyu Chen, Zezheng Gao, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 37
Chongxiang Xue, Keyu Chen, Zezheng Gao, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 37
Multifunctional hybrid exosomes enhanced cancer chemo-immunotherapy by activating the STING pathway
Lili Cheng, Peng Zhang, Yadong Liu, et al.
Biomaterials (2023) Vol. 301, pp. 122259-122259
Closed Access | Times Cited: 32
Lili Cheng, Peng Zhang, Yadong Liu, et al.
Biomaterials (2023) Vol. 301, pp. 122259-122259
Closed Access | Times Cited: 32
The effects of MYC on tumor immunity and immunotherapy
Jiajin Li, Tingyu Dong, Zhenhua Wu, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 31
Jiajin Li, Tingyu Dong, Zhenhua Wu, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 31
Injectable hydrogels for personalized cancer immunotherapies
Neda Mohaghegh, Amir Ahari, Fatemeh Zehtabi, et al.
Acta Biomaterialia (2023) Vol. 172, pp. 67-91
Open Access | Times Cited: 31
Neda Mohaghegh, Amir Ahari, Fatemeh Zehtabi, et al.
Acta Biomaterialia (2023) Vol. 172, pp. 67-91
Open Access | Times Cited: 31
JunB: a paradigm for Jun family in immune response and cancer
Fujia Ren, Xiaoyu Cai, Yao Yao, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 28
Fujia Ren, Xiaoyu Cai, Yao Yao, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 28
Supramolecular Biomaterials for Cancer Immunotherapy
Huan Liang, Qingqing Lu, Jie Yang, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 27
Huan Liang, Qingqing Lu, Jie Yang, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 27
Tumor cell membrane‐based vaccines: A potential boost for cancer immunotherapy
Muyang Yang, Jie Zhou, Liseng Lu, et al.
Exploration (2024) Vol. 4, Iss. 6
Open Access | Times Cited: 12
Muyang Yang, Jie Zhou, Liseng Lu, et al.
Exploration (2024) Vol. 4, Iss. 6
Open Access | Times Cited: 12
The role of dendritic cells in cancer immunity and therapeutic strategies
Yunze Tai, Man Chen, Fang Wang, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111548-111548
Closed Access | Times Cited: 11
Yunze Tai, Man Chen, Fang Wang, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111548-111548
Closed Access | Times Cited: 11
Dysfunction of dendritic cells in tumor microenvironment and immunotherapy
Jie Chen, Yu-Hang Duan, Junye Che, et al.
Cancer Communications (2024) Vol. 44, Iss. 9, pp. 1047-1070
Open Access | Times Cited: 10
Jie Chen, Yu-Hang Duan, Junye Che, et al.
Cancer Communications (2024) Vol. 44, Iss. 9, pp. 1047-1070
Open Access | Times Cited: 10
Dendritic cell subsets and implications for cancer immunotherapy
Michael Y. Chen, Felicia Zhang, S. Peter Goedegebuure, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Michael Y. Chen, Felicia Zhang, S. Peter Goedegebuure, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Dendritic cells in triple-negative breast cancer: From pathophysiology to therapeutic applications
Ana Isabel Sebastião, Gabriel Chahade Sibanto Simões, Filomena Oliveira, et al.
Cancer Treatment Reviews (2025) Vol. 133, pp. 102884-102884
Open Access | Times Cited: 1
Ana Isabel Sebastião, Gabriel Chahade Sibanto Simões, Filomena Oliveira, et al.
Cancer Treatment Reviews (2025) Vol. 133, pp. 102884-102884
Open Access | Times Cited: 1
Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunity
Madhav Sharma, Rafał Pacholczyk, Huidong Shi, et al.
Immunity (2021) Vol. 54, Iss. 10, pp. 2354-2371.e8
Open Access | Times Cited: 52
Madhav Sharma, Rafał Pacholczyk, Huidong Shi, et al.
Immunity (2021) Vol. 54, Iss. 10, pp. 2354-2371.e8
Open Access | Times Cited: 52
